Inamed Performance Enhanced By Tech Assessment: Shares Up 38% In May
This article was originally published in The Gray Sheet
Executive Summary
Positive safety results from an NIH-sponsored, retrospective study of silicon gel breast implants triggered a $14.25 leap in Inamed shares for the month of May